Carl Zeiss Meditec Forecast, price target & analysts
Carl Zeiss Meditec Target price 2025 - Analyst rating & recommendation
Carl Zeiss Meditec Classifications & Recommendation:
Carl Zeiss Meditec Price Target
| Target Price | €60.62 |
| Price | €63.95 |
| Deviation |
5.21%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Carl Zeiss Meditec 2026 .
The average Carl Zeiss Meditec target price is €60.62.
This is
5.21%
register free of charge
€90.00
40.73%
register free of charge
€41.00
35.89%
register free of charge
|
|
| A rating was issued by 17 analysts: 7 Analysts recommend Carl Zeiss Meditec to buy, 9 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Carl Zeiss Meditec stock has an average upside potential 2026 of
5.21%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion € | 2.07 | 2.18 |
| 1.11% | 5.45% | |
| EBITDA Margin | 17.59% | 17.80% |
| 15.88% | 1.18% | |
| Net Margin | 8.52% | 7.05% |
| 37.46% | 17.22% |
17 Analysts have issued a sales forecast Carl Zeiss Meditec 2025 . The average Carl Zeiss Meditec sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Carl Zeiss Meditec EBITDA forecast 2025. The average Carl Zeiss Meditec EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Carl Zeiss Meditec Analysts have issued a net profit forecast 2025. The average Carl Zeiss Meditec net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | 2.01 | 1.76 |
| 38.15% | 12.44% | |
| P/E | 36.43 | |
| EV/Sales | 2.86 |
13 Analysts have issued a Carl Zeiss Meditec forecast for earnings per share. The average Carl Zeiss Meditec EPS is
This results in the following potential growth metrics and future valuations:
Carl Zeiss Meditec...
Current Carl Zeiss Meditec Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Jan 05 2025 |
| DZ BANK |
Locked
➜
Locked
|
Locked | Dec 18 2024 |
| METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Dec 17 2024 |
| EQUITA SIM |
Locked
➜
Locked
|
Locked | Dec 15 2024 |
| LANDESBANK BADEN-WUERTTEMBERG |
Locked
➜
Locked
|
Locked | Dec 15 2024 |
| EQUI.TS |
Locked
➜
Locked
|
Locked | Dec 12 2024 |
| MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Jan 05 2025 |
|
Locked
DZ BANK:
Locked
➜
Locked
|
Dec 18 2024 |
|
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Dec 17 2024 |
|
Locked
EQUITA SIM:
Locked
➜
Locked
|
Dec 15 2024 |
|
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
➜
Locked
|
Dec 15 2024 |
|
Locked
EQUI.TS:
Locked
➜
Locked
|
Dec 12 2024 |
|
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Dec 11 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
